BiotechTube
Home/NanoViricides/Dr. Mak Jawadekar
DM

Dr. Mak Jawadekar

Independent Board Member

NanoViricides

Therapeutic Areas

Infectious DiseaseVirologyDermatologyOphthalmology

NanoViricides Pipeline

DrugIndicationPhase
NV-387MPox / SmallpoxPhase 2
NV-HHV-1 (HerpeCide)Shingles (VZV) - Topical CreamPreclinical
HerpeCide ProgramHSV-1 (Cold Sores)Preclinical
HIVCideHIV (Potential Functional Cure)Preclinical
NanoViricidesDengue VirusPreclinical

Leadership Team at NanoViricides

DA
Dr. Anil R. Diwan
Executive Chairman, President
DR
Dr. Randall Barton
Chief Scientific Officer
MM
Ms. Meeta Vyas
Chief Financial Officer
MJ
Mr. Jayant Tatake
Vice President, R&D
View full NanoViricides profile